Showing results (421-430 of 538) with videos related to
Sort By:
Pageof 54
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 1998
Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patientsS G Revankar, O P Dib, W R Kirkpatrick, et al.Antimicrobial Agents and Chemotherapy|September 15, 2001
Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patientsS Perea, J L López-Ribot, W R Kirkpatrick, et al.Antimicrobial Agents and Chemotherapy|December 28, 2007
Assessment of serum (1->3)-beta-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosisNathan P Wiederhold, Laura K Najvar, Ana C Vallor, et al.Medicine|August 15, 2000
Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study GroupT F Patterson, W R Kirkpatrick, M White, et al.Journal of Clinical Microbiology|February 8, 2003
Multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiationSpencer W Redding, William R Kirkpatrick, Stephen Saville, et al.APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 20, 2023
Screening the medicine for malaria venture's Pandemic Response Box to identify novel inhibitors of Candida albicans and Candida auris biofilm formationOlabayo H Ajetunmobi, Ashok K Chaturvedi, Hamid Badali, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2015
Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen TestingP Lewis White, John R Wingard, Stéphane Bretagne, et al.Medical Mycology|January 30, 2013
Prolyl endopeptidase activity in bronchoalveolar lavage fluid: a novel diagnostic biomarker in a guinea pig model of invasive pulmonary aspergillosisKalyani Jambunathan, Douglas S Watson, Laura K Najvar, et al.BMC Infectious Diseases|February 25, 2014
Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trialJose Vazquez, Annette C Reboli, Peter G Pappas, et al.Antimicrobial Agents and Chemotherapy|September 1, 1996
Systemic availability of itraconazole in lung transplantationT F Patterson, J Peters, S M Levine, et al.Pageof 54